BioSpace News Archive

Tarsus Pharmaceuticals, Inc. today announced that it will host a live webcast on Tuesday, February 8th at 9 a.m. pacific time for a corporate update and to provide expert clinical perspectives on Demodex blepharitis (DB) and the potential of TP-03 to treat this disease.

SomaLogic, Inc., a leader in AI-data driven proteomics technology, announced that the company will be participating in the following virtual investor conferences.

Entasis Therapeutics Holdings Inc. today announced that its Board of Directors received a preliminary, non-binding proposal from its majority stockholder Innoviva, Inc. (“Innoviva”) to acquire all of the outstanding equity securities of Entasis that are not currently owned by Innoviva for a per share consideration of $1.80 payable in cash.

Mirati Therapeutics, Inc., a clinical-stage targeted oncology company, will participate in two upcoming healthcare conferences.

Labcorp (NYSE: LH), a leading global life sciences company, has been named to FORTUNE® magazine’s 2022 list of the World’s Most Admired Companies, marking its fourth appearance on the list.

Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced that Nicole LaBrosse has been promoted to the position of senior vice president, chief financial officer, effective immediately.

Exelixis, Inc. announced that company management will participate in a fireside chat at the virtual Guggenheim Healthcare Talks Oncology Day on Wednesday, February 9, 2022 at 1:30pm ET / 10:30am PT.

NuGen Medical Devices Inc. is pleased to announce that, further to its press release of January 20, 2022, it has settled an aggregate of $500,000 of indebtedness owed to an arm’s length creditor with respect to royalty payments due to the Creditor through the issuance of an aggregate of 1,644,736 common shares of the Company at a price of $0.304 per Common Share.